A
Bioadvance-Biotechnology 3701 Market Street Category: Venture Capital Companies |
Company representatives
Isaiah Campbell, Cio/Cto
Philip Gerbino, Chairman
John Daly, Board Member
Marnie Mccoy, Board Member
Location Type
Single Location
Revenue
$7,250,000 - $7,500,000
Employees
5 to 9
State of incorporation
Information not found
SIC code
679998 (Venture Capital Companies)
NAICS code
523910 (Misc Intermediation)
Rating
Browse U.S. states for Venture Capital Companies
